Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18-64 years in BCBS of Texas.
Jung Hyun KimSuja S RajanXianglin L DuLuisa FranziniSharon H GiordanoRobert O MorganPublished in: Breast cancer research and treatment (2018)
Financial burdens including both non-AHT medication and AHT-specific out-of-pocket costs were significantly associated with adherence and persistence to the therapy.